Tuberculosis Diagnostics Market anticipated to
reach USD 3.1 billion by 2024
Global Tuberculosis Diagnostics Market is anticipated to reach USD 3.1 billion by 2024 owing to the
introduction of enhanced diagnostic techniques like serological methods, IGRA (Interferon-gamma Release
Assay), and nucleic acid testing. Tuberculosis is an infectious disorder caused by mycobacterium tuberculosis
bacteria that attacks the lungs. The disorder can also spread to the other parts of the body like spine and brain.
Depending on the type of tuberculosis suspected in the body, several tests are available for the diagnosis.
Tuberculosis diagnostics industry is influenced by factors like quick results and improved accuracy, increasing
government initiatives, growing elderly population and rising need for POC in healthcare sector. However,
tuberculosis diagnostics market is restrained by significant cost of tuberculosis diagnosis and lack of awareness
in patients. Additionally, the increasing burden of tuberculosis is the major factor expected to bring greater
opportunities in tuberculosis diagnostics industry.
Tuberculosis diagnostics market is categorized on the basis of test type, end user, and geography. On the basis
of test type, the market is divided into diagnostic laboratory methods, detection of latent infection, nucleic acid
testing, cytokine detection assay, detection of drug resistance, radiographic method, and others. Diagnostic
laboratory segment is projected to hold larger market share of tuberculosis diagnostics since it is easy to
perform and cost effective.
.Request Sample Copy of This Market Research @ https://www.millioninsights.com/industry-
Based on end user, tuberculosis diagnostics industry is divided into clinics, research institutes & academics,
reference laboratories, hospitals, and others. Hospital segment is predicted to register significant growth in the
coming years owing to rising preference for well-organized healt